Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891708682> ?p ?o ?g. }
- W2891708682 abstract "Abstract About 60% of RA patients don’t achieve good response with biological disease-modifying anti-rheumatic drugs bDMARD treatment (including TNF inhibitors, TNFi’s). Previously, a link between TNFα and interleukin (IL)-32 was reported in RA. However, the exact mechanism linking IL-32 to response to treatment as not been studied yet. Therefore, we explored the influence of a promoter single nucleotide polymorphism (SNP) rs4786370 in IL-32 on clinical responsiveness to TNFi’s in RA patients, potentially serving as new biomarker in RA. Expression of pro-inflammatory cytokines by peripheral mononuclear cells (PBMCs) from RA patients and healthy individuals were studied. Moreover, “ ex vivo response ” and clinical response to anti-TNFα therapy (etanercept, adalimumab) were measured and stratified for the IL-32 SNP. Higher IL-32 protein production was observed in RA patients. Additionally, patients bearing the CC genotype showed higher IL-32 protein and cytokine expression. DAS28 was independent of the promoter SNP, however, the “ ex vivo” cytokine response was not. IL-32 mRNA and protein production was higher in RA patients, with a trend towards higher concentrations in patients bearing the CC genotype. Furthermore, genotype dependent IL-1 beta production might predict clinical response to etanercept/adalimumab. This indicates that IL-32 could play a role in predicting response to treatment in RA." @default.
- W2891708682 created "2018-09-27" @default.
- W2891708682 creator A5004798446 @default.
- W2891708682 creator A5030365370 @default.
- W2891708682 creator A5036752858 @default.
- W2891708682 creator A5044687501 @default.
- W2891708682 creator A5071611042 @default.
- W2891708682 creator A5076200839 @default.
- W2891708682 creator A5077664248 @default.
- W2891708682 date "2018-09-19" @default.
- W2891708682 modified "2023-10-10" @default.
- W2891708682 title "Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients" @default.
- W2891708682 cites W1866259979 @default.
- W2891708682 cites W1981274829 @default.
- W2891708682 cites W1983530785 @default.
- W2891708682 cites W1993815621 @default.
- W2891708682 cites W2006571737 @default.
- W2891708682 cites W2024143240 @default.
- W2891708682 cites W2024651299 @default.
- W2891708682 cites W2056813079 @default.
- W2891708682 cites W2074438676 @default.
- W2891708682 cites W2077048680 @default.
- W2891708682 cites W2101840353 @default.
- W2891708682 cites W2103310388 @default.
- W2891708682 cites W2103927530 @default.
- W2891708682 cites W2106171259 @default.
- W2891708682 cites W2118434900 @default.
- W2891708682 cites W2120063937 @default.
- W2891708682 cites W2122833930 @default.
- W2891708682 cites W2127848583 @default.
- W2891708682 cites W2133692536 @default.
- W2891708682 cites W2143494794 @default.
- W2891708682 cites W2149883686 @default.
- W2891708682 cites W2155702314 @default.
- W2891708682 cites W2158854507 @default.
- W2891708682 cites W2162325434 @default.
- W2891708682 cites W2172153430 @default.
- W2891708682 cites W2273452210 @default.
- W2891708682 cites W2582243563 @default.
- W2891708682 cites W2588239649 @default.
- W2891708682 cites W43443165 @default.
- W2891708682 doi "https://doi.org/10.1038/s41598-018-32485-0" @default.
- W2891708682 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6145899" @default.
- W2891708682 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30232372" @default.
- W2891708682 hasPublicationYear "2018" @default.
- W2891708682 type Work @default.
- W2891708682 sameAs 2891708682 @default.
- W2891708682 citedByCount "11" @default.
- W2891708682 countsByYear W28917086822019 @default.
- W2891708682 countsByYear W28917086822020 @default.
- W2891708682 countsByYear W28917086822021 @default.
- W2891708682 countsByYear W28917086822022 @default.
- W2891708682 countsByYear W28917086822023 @default.
- W2891708682 crossrefType "journal-article" @default.
- W2891708682 hasAuthorship W2891708682A5004798446 @default.
- W2891708682 hasAuthorship W2891708682A5030365370 @default.
- W2891708682 hasAuthorship W2891708682A5036752858 @default.
- W2891708682 hasAuthorship W2891708682A5044687501 @default.
- W2891708682 hasAuthorship W2891708682A5071611042 @default.
- W2891708682 hasAuthorship W2891708682A5076200839 @default.
- W2891708682 hasAuthorship W2891708682A5077664248 @default.
- W2891708682 hasBestOaLocation W28917086821 @default.
- W2891708682 hasConcept C104317684 @default.
- W2891708682 hasConcept C135763542 @default.
- W2891708682 hasConcept C137061746 @default.
- W2891708682 hasConcept C139275648 @default.
- W2891708682 hasConcept C150903083 @default.
- W2891708682 hasConcept C153209595 @default.
- W2891708682 hasConcept C17991360 @default.
- W2891708682 hasConcept C187316574 @default.
- W2891708682 hasConcept C202751555 @default.
- W2891708682 hasConcept C203014093 @default.
- W2891708682 hasConcept C207001950 @default.
- W2891708682 hasConcept C26291073 @default.
- W2891708682 hasConcept C2777138892 @default.
- W2891708682 hasConcept C2777226972 @default.
- W2891708682 hasConcept C2777575956 @default.
- W2891708682 hasConcept C2778690821 @default.
- W2891708682 hasConcept C2780132546 @default.
- W2891708682 hasConcept C2781197716 @default.
- W2891708682 hasConcept C55493867 @default.
- W2891708682 hasConcept C71924100 @default.
- W2891708682 hasConcept C86803240 @default.
- W2891708682 hasConceptScore W2891708682C104317684 @default.
- W2891708682 hasConceptScore W2891708682C135763542 @default.
- W2891708682 hasConceptScore W2891708682C137061746 @default.
- W2891708682 hasConceptScore W2891708682C139275648 @default.
- W2891708682 hasConceptScore W2891708682C150903083 @default.
- W2891708682 hasConceptScore W2891708682C153209595 @default.
- W2891708682 hasConceptScore W2891708682C17991360 @default.
- W2891708682 hasConceptScore W2891708682C187316574 @default.
- W2891708682 hasConceptScore W2891708682C202751555 @default.
- W2891708682 hasConceptScore W2891708682C203014093 @default.
- W2891708682 hasConceptScore W2891708682C207001950 @default.
- W2891708682 hasConceptScore W2891708682C26291073 @default.
- W2891708682 hasConceptScore W2891708682C2777138892 @default.
- W2891708682 hasConceptScore W2891708682C2777226972 @default.
- W2891708682 hasConceptScore W2891708682C2777575956 @default.
- W2891708682 hasConceptScore W2891708682C2778690821 @default.
- W2891708682 hasConceptScore W2891708682C2780132546 @default.